K & B National Research, LLC – Trademark Portfolio
Entity Type: 16
K & B National Research, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LIVEVIEW, FOCUS GROUPS OF AMERICA, and FGA FOCUS GROUPS OF AMERICA. The owner is based in Dallas, TX.
12160 Abrams Rd., Ste. 635
Dallas, TX 75243
Showing of trademarks Trademarks
Trademark Classifications
K & B National Research, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does K & B National Research, LLC have?
K & B National Research, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does K & B National Research, LLC file in?
K & B National Research, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are K & B National Research, LLC's most well-known trademarks?
K & B National Research, LLC's registered trademark portfolio includes well-known marks such as LIVEVIEW, FOCUS GROUPS OF AMERICA, and FGA FOCUS GROUPS OF AMERICA. These are among 3 currently registered trademarks in the portfolio.
What is K & B National Research, LLC's trademark registration success rate?
K & B National Research, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.